Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthijs Oyaert

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Therapeutic Drug Monitoring|December 20, 2014
Key Elements in Determining Voriconazole Protein Binding Characteristics: Comment on "Determination of Plasma Unbound Fraction of Voriconazole in Patients Treated With a Prophylactic or a Curative Treatment"Kim Vanstraelen, Steven Pauwels, Matthijs Oyaert, et al.
Kidney International Reports|August 15, 2025
Renal Tubular Epithelial Cells as Marker of Tubular Damage in Acute Kidney DiseaseMatthijs Oyaert, Sigurd Delanghe, Joris Delanghe, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 17, 2017
A negative lactate dehydrogenase activity corrected after sample neuraminidase treatmentMatthijs Oyaert, Tom Van Maerken, Evelien Bauwens, et al.
International Journal of Systematic and Evolutionary Microbiology|June 20, 2014
Atopobium deltae sp. nov., isolated from the blood of a patient with Fournier's gangrenePiet Cools, Matthijs Oyaert, Mario Vaneechoutte, et al.
Kidney International|June 22, 2023
Glucosuria and interference of urinary albumin-to-creatinine ratioJoris Delanghe, Matthijs Oyaert, Marc De Buyzere, et al.
Journal of Clinical Medicine|December 9, 2023
From Vibrations to Visions: Raman Spectroscopy's Impact on Skin Cancer DiagnosticsCharlotte Delrue, Reinhart Speeckaert, Matthijs Oyaert, et al.
Clinical Chemistry and Laboratory Medicine|September 14, 2022
About the estimation of albuminuria based on proteinuria resultsJoris R Delanghe, Matthijs Oyaert, Marc L De Buyzere, et al.
Clinical Chemistry and Laboratory Medicine|September 25, 2015
Practical approach for medical validation of therapeutic drug monitoring resultsMatthijs Oyaert, Inger Brandt, Pieter Vermeersch, et al.
Clinical Chemistry and Laboratory Medicine|January 29, 2020
L-index, more than a screening tool for hypertriglyceridemiaJoris R Delanghe, Matthijs Oyaert, Marijn M Speeckaert, et al.
Clinical Chemistry and Laboratory Medicine|July 25, 2019
Non-linearity in commercially available lipase assays: still gaps to closeMatthijs Oyaert, Joris Delanghe, Jan Van den Bossche, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Therapeutic Drug Monitoring|December 20, 2014
Key Elements in Determining Voriconazole Protein Binding Characteristics: Comment on "Determination of Plasma Unbound Fraction of Voriconazole in Patients Treated With a Prophylactic or a Curative Treatment"Kim Vanstraelen, Steven Pauwels, Matthijs Oyaert, et al.
Kidney International Reports|August 15, 2025
Renal Tubular Epithelial Cells as Marker of Tubular Damage in Acute Kidney DiseaseMatthijs Oyaert, Sigurd Delanghe, Joris Delanghe, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|March 17, 2017
A negative lactate dehydrogenase activity corrected after sample neuraminidase treatmentMatthijs Oyaert, Tom Van Maerken, Evelien Bauwens, et al.
International Journal of Systematic and Evolutionary Microbiology|June 20, 2014
Atopobium deltae sp. nov., isolated from the blood of a patient with Fournier's gangrenePiet Cools, Matthijs Oyaert, Mario Vaneechoutte, et al.
Kidney International|June 22, 2023
Glucosuria and interference of urinary albumin-to-creatinine ratioJoris Delanghe, Matthijs Oyaert, Marc De Buyzere, et al.
Journal of Clinical Medicine|December 9, 2023
From Vibrations to Visions: Raman Spectroscopy's Impact on Skin Cancer DiagnosticsCharlotte Delrue, Reinhart Speeckaert, Matthijs Oyaert, et al.
Clinical Chemistry and Laboratory Medicine|September 14, 2022
About the estimation of albuminuria based on proteinuria resultsJoris R Delanghe, Matthijs Oyaert, Marc L De Buyzere, et al.
Clinical Chemistry and Laboratory Medicine|September 25, 2015
Practical approach for medical validation of therapeutic drug monitoring resultsMatthijs Oyaert, Inger Brandt, Pieter Vermeersch, et al.
Clinical Chemistry and Laboratory Medicine|January 29, 2020
L-index, more than a screening tool for hypertriglyceridemiaJoris R Delanghe, Matthijs Oyaert, Marijn M Speeckaert, et al.
Clinical Chemistry and Laboratory Medicine|July 25, 2019
Non-linearity in commercially available lipase assays: still gaps to closeMatthijs Oyaert, Joris Delanghe, Jan Van den Bossche, et al.
Pageof 8